Prim SA
F:5P1
Prim SA
F:5P1
Price:
12.55
EUR
2.03%
Market Closed
Market Cap:
€213.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Prim SA
F:5P1
|
ES |
|
G
|
Gold Royalty Corp
AMEX:GROY
|
CA |
|
Ares Management Corp
NYSE:ARES
|
US |
|
Walchandnagar Industries Ltd
NSE:WALCHANNAG
|
IN |
|
S
|
Seagate Technology Holdings PLC
XBER:847
|
SG |
|
B
|
Bactiquant A/S
CSE:BACTIQ
|
DK |
|
GB Sciences Inc
OTC:GBLX
|
US |
|
G
|
Golden MV Holdings Inc
XPHS:HVN
|
PH |
|
C
|
Cera Sanitaryware Ltd
NSE:CERA
|
IN |
|
Itochu-Shokuhin Co Ltd
TSE:2692
|
JP |
|
T
|
TubeSolar AG
XETRA:9TS
|
DE |
|
A
|
Arrivent Biopharma Inc
NASDAQ:AVBP
|
US |
|
Sterling Group Holdings Ltd
HKEX:1825
|
HK |
|
G
|
Global Blood Therapeutics Inc
F:G5B
|
US |
|
Magnolia Oil & Gas Corp
NYSE:MGY
|
US |
|
Polaris Infrastructure Inc
TSX:PIF
|
CA |
Multiples-Based Value
The Multiples-Based Value of one
5P1
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 12.55 EUR,
Prim SA
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
5P1 Multiples-Based Value
LOCKED
Multiples Across Competitors
5P1 Competitors Multiples
Prim SA Competitors
Prim SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ES |
|
Prim SA
F:5P1
|
217m EUR | 0.9 | 14.9 | 11.2 | 11.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
177.8B USD | 4 | 27.3 | 15.6 | 21.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
164.9B USD | 16.4 | 57.7 | 43.7 | 53.8 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126B USD | 5 | 38.8 | 19.9 | 24 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.4B USD | 3.1 | 23.9 | 13.3 | 19.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
91.9B USD | 4.6 | 31.7 | 18.8 | 25.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41B EUR | 1.8 | 19.4 | 10.9 | 15.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD | 7.8 | 44 | 24.2 | 26.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45B USD | 10.5 | 42.5 | 30.1 | 33.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.5B USD | 2 | 25.3 | 10 | 16.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.5B USD | 6 | 21.8 | 15.3 | 17 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
